OcuTerra Appoints Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs
BOSTON--(BUSINESS WIRE)--OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of “watch-and-wait” does not prevent or control the progression of disease, today announced the appointment of eye care industry veteran Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs. Dr. Anderesi previously served as Global Medical Affairs Director for the Novartis Ophtha